Brochure: The SLICE® Sustainability Project (4222kb)
The SLICE® Sustainability Project is a global initiative by the Aquatic Animal Health business of Intervet/Schering-Plough Animal Health, the world’s leading animal health company for aquaculture.
SLICE® Bioassay Protocol (100kb)
Bioassay protocol for in vitro determination of sea lice sensitivity to emamectin benzoate
Bioassays are an important tool for determining the sensitivity of sea lice to treatments. They can be used routinely throughout the growing cycle to help predict the sensitivity of sea lice to available treatments or to detect changes in sensitivity within a population of sea lice...
SLICE® Guidelines (118kb)
Guidelines for sampling of feed medicated with SLICE® (emamectin benzoate)
Proper manufacture of medicated feeds and administration of the correct dosage are essential to help ensure successful treatment of fish, prevent sub-optimal drug delivery and
minimize pressure for the selection of resistance.
SLICE® Resistance Management (206kb)
Best-practice treatment principles: Sea lice resistance management, 2010
In September 2000, Intervet/Schering-Plough Animal Health published a technical bulletin entitled Sea Lice Resistance Management (with particular reference to avermectins)...
SLICE® Stability of Emamectin (93kb)
Stability of emamectin benzoate in methanol stock solution at three different temperatures
Bioassays are increasingly being used as a tool to predict sensitivity or to detect changes in sensitivity of sea lice to available sea lice treatments; methods are available for conducting bioassays with pyrethroids (deltamethrin [Alphamax®] and cypermethrin [Excis®]), azimethiphos [Salmosan®] and emamectin benzoate [SLICE®]...
